Reaction Details |
| Report a problem with these data |
Target | Bile acid receptor |
---|
Ligand | BDBM21674 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_793021 (CHEMBL1932587) |
---|
EC50 | 16800±n/a nM |
---|
Citation | Schuster, D; Markt, P; Grienke, U; Mihaly-Bison, J; Binder, M; Noha, SM; Rollinger, JM; Stuppner, H; Bochkov, VN; Wolber, G Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation. Bioorg Med Chem19:7168-80 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Bile acid receptor |
---|
Name: | Bile acid receptor |
Synonyms: | Bar | Farnesoid X-activated receptor | Farnesol receptor HRR-1 | Fxr | NR1H4_MOUSE | Nr1h4 | Nuclear receptor subfamily 1 group H member 4 | RXR-interacting protein 14 | Retinoid X receptor-interacting protein 14 | Rip14 |
Type: | PROTEIN |
Mol. Mass.: | 55996.68 |
Organism: | Mus musculus |
Description: | ChEMBL_793021 |
Residue: | 488 |
Sequence: | MVMQFQGLENPIQISLHHSHRLSGFVPEGMSVKPAKGMLTEHAAGPLGQNLDLESYSPYN
NVPFPQVQPQISSSSYYSNLGFYPQQPEDWYSPGIYELRRMPAETGYQGETEVSEMPVTK
KPRMAAASAGRIKGDELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNC
VMDMYMRRKCQECRLRKCKEMGMLAECMYTGLLTEIQCKSKRLRKNVKQHADQTANEDDS
EGRDLRQVTSTTKFCREKTELTADQQTLLDYIMDSYNKQRMPQEITNKILKEEFSAEENF
LILTEMATSHVQILVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPAGH
ADLLEERIRKSGISDEYITPMFSFYKSVGELKMTQEEYALLTAIVILSPDRQYIKDREAV
EKLQEPLLDVLQKLCKMYQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPL
LCEIWDVQ
|
|
|
BDBM21674 |
---|
n/a |
---|
Name | BDBM21674 |
Synonyms: | (4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid | CDCA | CHENODIOL | Chenodeoxycholic Acid | US10208081, CDCA |
Type | Steroid |
Emp. Form. | C24H40O4 |
Mol. Mass. | 392.572 |
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O |
Structure |
|